Effect of Fexofenadine/Pseudoephedrine combination tablet on Nasal Obstruction in Patients with Allergic Rhinitis

Effect of Fexofenadine/Pseudoephedrine combination tablet on Nasal Obstruction in Patients with Allergic Rhinitis - Effect of Fexofenadine/Pseudoephedrine combination tablet on Nasal Obstruction in Patients with Allergic Rhinitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041845

Enrollment

Registered

2020-09-18

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

measure nasal airflow for 8 hours at 30-minute intervals after taking a single agent: fexofenadine/pseudoephedrine combination tablet measure nasal airflow for 8 hours at 30-minute intervals after tak

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) with a history of allergic rhinitis (2) with nasal obstruction (3) house dust mite allergy based on skin reactions or serum allergen-specific IgE antibody measurements.

Exclusion criteria

Exclusion criteria: (1) upper respiratory tract infection (2) allergen-specific immunotherapy (3) pregnancy, or lactation (4) patients with hypertension, severe asthma (5)a history of known hypersensitivity, allergic reactions

Design outcomes

Primary

Measure	Time frame
nasal airflow	—

Countries

Japan

Contacts

Public ContactYosuke Nakamura

Faculty of Medicine, Tottori University Division of Otolaryngology, Head and Neck Surgery, Department of Medicine of Sensory and Motor Organ

yosuken@tottori-u.ac.jp0859-38-6627

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026